Silence Therapeutics News

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Moomoo NewsNov 6 07:31 ET

Buy Rating for Silence Therapeutics: Promising Phase 1 Results and Future Prospects

TipRanksNov 6 07:11 ET

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Moomoo NewsOct 21 09:35 ET

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Moomoo NewsOct 7 09:34 ET

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Moomoo NewsSep 23 09:31 ET

Jefferies Initiates Silence Therapeutics(SLN.US) With Buy Rating, Announces Target Price $40

Moomoo NewsSep 2 10:32 ET

Silence Therapeutics Analyst Ratings

BenzingaAug 30 05:44 ET

H.C. Wainwright Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $75

Moomoo NewsAug 29 13:32 ET

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Moomoo NewsAug 26 09:32 ET

Morgan Stanley Reaffirms Their Buy Rating on Silence Therapeutics (SLN)

TipRanksAug 26 09:19 ET

Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Pharvaris (PHVS) and Stevanato Group (STVN)

TipRanksAug 26 09:19 ET

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Moomoo NewsAug 19 09:33 ET

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Moomoo NewsAug 16 09:32 ET

BMO Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $67

Moomoo NewsAug 16 07:31 ET

Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49

Moomoo NewsAug 16 06:34 ET

Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $55

Moomoo NewsAug 15 20:32 ET

Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Silence Therapeutics (SLN) and Exscientia Plc (EXAI)

TipRanksJul 22 08:17 ET

Silence Therapeutics (SLN) Receives a Buy From Morgan Stanley

TipRanksJul 15 08:28 ET

Silence Therapeutics (SLN) Gets a Buy From Morgan Stanley

TipRanksJul 8 08:29 ET

Morgan Stanley Raises Price Target on Silence Therapeutics to $49 From $45, Keeps Overweight Rating

MT NewswiresJun 28 06:17 ET